image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
53fc683fb4dcc66c7b5f3ddbadab4fb700d7d42eae0be3c7fabe882709da5872.png
complex
<table><tr><td> </td><td colspan="2">Standard margin</td><td colspan="2">Reduced margin</td><td> </td><td> </td><td> </td></tr><tr><td>Parameter</td><td>Mean</td><td>St. Dev.</td><td>Mean</td><td>St. Dev.</td><td>Difference (Gy)</td><td>(%)</td><td>p-value</td></tr><tr><td>Max dose (Gy)</td><td>61.4</td><td>1.4</td><td...
86368ec1cb1e07452ff05e37cb2e59b09581e67612b38eb06bf3aa1a96ae5f28.png
complex
<table><tr><td></td><td colspan="2">PACCE oxaliplatin cohort [43]</td><td colspan="2">CAIRO2 [47]</td></tr><tr><td></td><td colspan="2"> (<i>N</i> = 823)</td><td colspan="2">(<i>N</i> = 755)</td></tr><tr><td></td><td>Ox + Bev + Pmab</td><td>Ox + Bev</td><td>Cap, Ox + Bev + Cmab</td><td>Cap, Ox + Bev</td></tr><tr><td>Me...
3c6b6819c2c86dbcde79f00f776a2091c9f0979cac55918e4cc013896e399568.png
complex
<table><tr><td>Name</td><td>Sequence</td><td>Description</td></tr><tr><td><i>NIP5;1_qRT-PCR-1</i></td><td>caccgattttccctctcctgat</td><td rowspan="10">Probes for realtime PCR</td></tr><tr><td><i>NIP5;1_qRT-PCR-2</i></td><td>ctctttcttactctctagcctc</td></tr><tr><td><i>NIP5;1_qRT-PCR-3</i></td><td>gaatgttcccacgaactcgg</td>...
6cf2b3a4f5e9b1e3668d41787799866e33baea85ee3398544f79d2f6d1b52da8.png
simple
<table><tr><td>sCr (mg/dl)</td><td>AKI group</td><td>non-AKI group</td><td><i>P</i> value</td></tr><tr><td></td><td>(<i>n</i> = 11)</td><td>(<i>n</i> = 39)</td><td></td></tr><tr><td>Preoperative</td><td>0.72 &#177; 0.14</td><td>0.68 &#177; 0.15</td><td>0.531</td></tr><tr><td>Postoperative</td><td></td><td></td><td></td...
782b33f1060d8206fde9e0d3df4f2b0cb56713f56ea20830ea3a3ca267a45e06.png
complex
<table><tr><td colspan="2">Germplasm or genotypes</td><td>Sites (No)</td><td>Reference</td></tr><tr><td>Type</td><td>Number</td><td></td><td></td></tr><tr><td>Natural accession</td><td>124</td><td>1</td><td>Mengesha et al. (1965)</td></tr><tr><td>Hybrids</td><td>559</td><td>1</td><td>Berhe et al. (1989a,b,c)</td></tr><...
9897bcf2700a8688846a677b613d7741670bab3877d817b39c784bb3d77835e6.png
complex
<table><tr><td>Variables</td><td>Categories</td><td colspan="8">Asthma confirmed by BHR</td></tr><tr><td></td><td></td><td colspan="4">Crude model</td><td colspan="4">Adjusted model</td></tr><tr><td></td><td></td><td>PR</td><td colspan="2">95 % CI</td><td><i>p</i> value</td><td>PR</td><td colspan="2">95 % CI</td><td><i...
1841538fa54707869d10914dda7789933d3772d8821dc739cd76d069ac621500.png
simple
<table><tr><td></td><td>ADHD group(<i>n </i>= 16)</td><td>Control group(<i>n </i>= 16)</td><td>Group differences<sup>a</sup></td></tr><tr><td></td><td>M (SD)</td><td>M (SD)</td><td></td></tr><tr><td>Age (years)</td><td>10.7 (1.6)</td><td>10.2 (1.3)</td><td>ns</td></tr><tr><td>IQ (WISC-III)</td><td>97.1 (14.2)</td><td>1...
8979775de6e6d790dd71d4b6ef5b196298df66bfc293f7e8dcf1b75f1f012678.png
complex
<table><tr><td>Fracture sites</td><td>No. of fractures</td><td>Fracture IR (/1000 PY)</td><td>Age/sex adjusted HR (95 % CI)</td><td>Adjusted HR (95 % CI)</td></tr><tr><td colspan="5">Major osteoporotic fracture</td></tr><tr><td> Never-GLP1-ra use<sup>a</sup></td><td>4373</td><td>6.1</td><td>Reference</td><td>Reference<...
de08d6f43d8f83c166735facfeeddc1b203ec5660a4a5111cd5036af9f33ee8e.png
complex
<table><tr><td></td><td></td><td></td><td colspan="3">Age</td><td colspan="3">Gender</td></tr><tr><td>EVA derivative</td><td>Intercept</td><td>R<sup>2</sup></td><td>B</td><td>&#946;</td><td>p</td><td>B</td><td>&#946;</td><td><i>p</i></td></tr><tr><td>Prolonged sitting (&gt;30 min)</td><td>&#8722;30.6</td><td>.01</td><t...
7f03fe2d406922d39e89ca593beab7aea7d5b0c970e4a0d515ba19f5d9f373a9.png
simple
<table><tr><td>Accession no.</td><td>Strain</td><td>BioSample ID</td><td>BioProject ID</td></tr><tr><td>CP018252</td><td>9000</td><td>SAMN05544760</td><td>PRJNA336330</td></tr><tr><td>CP018250</td><td>10671</td><td>SAMN05544761</td><td>PRJNA336330</td></tr><tr><td>CP018247</td><td>7784</td><td>SAMN05544762</td><td>PRJN...
57c97298c16027babe6726ca2058ccf5280ec0b056394e5a0965bf569906f328.png
simple
<table><tr><td><i>n1</i></td><td><i>n2</i></td><td>Ratio</td><td>Distance</td></tr><tr><td>1</td><td>2</td><td>0.50</td><td>1</td></tr><tr><td>2</td><td>3</td><td>0.67</td><td>1</td></tr><tr><td>3</td><td>4</td><td>0.75</td><td>1</td></tr><tr><td>4</td><td>5</td><td>0.80</td><td>1</td></tr><tr><td>5</td><td>6</td><td>0...
887450ae95c874b12fd0c8b2d62eb6c37698bb939773802df044dccb91c5dbe0.png
complex
<table><tr><td></td><td>Composition</td><td>Strain-to-failure (mm/mm)</td><td>Stress-at-failure (MPa)</td><td>Toughness (MJ/m<sup>3</sup>)</td></tr><tr><td rowspan="4"><i>T</i> = temperature at loss modulus peak</td><td>5% BPA</td><td>1.43 &#177; 0.0985</td><td>11.9 &#177; 2.14</td><td>8.99 &#177; 1.72</td></tr><tr><td...
32f0a4ccd8f3903c430f13a002d1ff86186f191c25ea70e76581f604a1f85fc6.png
simple
<table><tr><td> </td><td>PR</td><td>GR</td><td>CS</td><td>OD</td><td>IT</td><td>FL</td></tr><tr><td>PR</td><td>&#8212;</td><td>MI</td><td>WI</td><td>EI</td><td>SI</td><td>VSI</td></tr><tr><td>GR</td><td></td><td>&#8212;</td><td></td><td>SMI</td><td></td><td></td></tr><tr><td>CS</td><td></td><td>WI</td><td>&#8212;</td><...
d38de7789e2352444ae7437eed4a53ead45816f1b5ba7ae98058ff2a5c230de2.png
complex
<table><tr><td colspan="4">Locus</td><td colspan="5">Initial Signal</td><td colspan="5">Regional Validation Signal</td></tr><tr><td>Chr</td><td>Position (Mb)</td><td>Gene</td><td>Prior HDL or Lipid Association [Ref]</td><td>Lead SNP</td><td>MA</td><td>MAF</td><td>Effect (mg/dl)</td><td><i>P</i>-value</td><td>Lead SNP</...
6ad8352aa5c400319828fa0956916c73cbc27e4ebcb55e665653a5c0ad8e2bb8.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">TNF-&#945; Stimulation (U/ml)</td></tr><tr><td>0</td><td>10</td><td>100</td></tr><tr><td>HUVECs in monocultures</td><td>4.9 &#177; 1.5</td><td>15.7 &#177; 0.8*</td><td>24.57 &#177; 3.01**</td></tr><tr><td>HUVECs in direct contact with podocytes</td><td>11.43 &#177; 4.7</t...
7dbd474ee782708a0fa7a54b85612aa415b66230d541f52c19746576350baa36.png
complex
<table><tr><td rowspan="2"></td><td>MD</td><td>Normal LV and RV function</td><td>Impaired LV and/or RV function</td><td rowspan="2"><i>p</i> value</td></tr><tr><td><i>N</i> = 63</td><td><i>N</i> = 31</td><td><i>N</i> = 32</td></tr><tr><td>Male, <i>n</i> (%)</td><td>63 (100)</td><td>31 (100)</td><td>32 (100)</td><td>1.0...
7e5f9992fc1f71c6cc754bb75cf545e80ead3275ec53f95e57d3423ff2de9a27.png
simple
<table><tr><td>Plasmid</td><td>Description</td><td>Source of reference</td></tr><tr><td>pGK423</td><td>Yeast expression vector containing <i>PGK1</i> promoter, 2 &#956; origin, <i>HIS3</i> marker, no expression (control plasmid)</td><td>Ishii et al. [10]</td></tr><tr><td>pGK426</td><td>Yeast expression vector containin...
fb958939ba8537f80aa5dc16bc69e997351c132bbf943b504a6fd8e5382e121b.png
simple
<table><tr><td>Source</td><td>Type III sum of squares</td><td>df</td><td>mean square</td><td>F</td><td>P</td></tr><tr><td>population</td><td>33.571</td><td>1</td><td>33.571</td><td>98.623</td><td>&lt; 0.001</td></tr><tr><td>sex</td><td>12.560</td><td>1</td><td>12.560</td><td>36.899</td><td>&lt; 0.001</td></tr><tr><td>p...
ddc1e05c6f99fb473c7f8ad9f4a99734d3b2618d98ed35a74c32f908f287d6cf.png
complex
<table><tr><td>Antibody(ies)</td><td>Number of patients</td><td>Percentage</td></tr><tr><td colspan="3">Alloantibodies</td></tr><tr><td>Anti-c</td><td>10</td><td>6.4</td></tr><tr><td>Anti-C</td><td>3</td><td>1.9</td></tr><tr><td>Anti-c and anti-E</td><td>10</td><td>6.4</td></tr><tr><td>Anti-C + D</td><td>8</td><td>5.1<...
e0392898e7c9e9c53e2fdc24038a41773f86e9d55318c317483fbdeb99e13bdb.png
simple
<table><tr><td>Genotype</td><td>Strain</td><td>Accession number</td><td>Genotype</td><td>Strain</td><td>Accession number</td></tr><tr><td>GI_1</td><td>NV-USA93</td><td>M87661</td><td>GII_6</td><td>SU3-JPN </td><td>AB039776</td></tr><tr><td>GI_2</td><td>SOV-GBR93</td><td>L07418</td><td>GII_7</td><td>GN273-USA93</td><td>...
96571da16e013dba98706c25f7499c3575136d33ec53716a39a275558c4c12cd.png
complex
<table><tr><td>Characteristic</td><td>Bipolar I(<i>n</i> = 1809)</td><td>Bipolar II(<i>n</i> = 922)</td><td>Total(<i>N</i> = 2731)</td></tr><tr><td colspan="4">Gender, <i>n</i> (%)</td></tr><tr><td> Male</td><td>752 (41.6)</td><td>340 (36.9)</td><td>1092 (40.0)</td></tr><tr><td> Female</td><td>1057 (58.4)</td><td>582 (...
b273f72720870a9eb0f06491269b21fa671e00ba3d8418576c983ccdf969ce79.png
simple
<table><tr><td> </td><td>0&#8211;30 days post-implant</td><td>31&#8211;60 days post-implant</td><td>61&#8211;90 days post-implant</td></tr><tr><td>Pacemaker</td><td>35%</td><td>30%</td><td>67%</td></tr><tr><td>ICD</td><td>36%</td><td>42%</td><td>66%</td></tr><tr><td>CRT-D</td><td>34%</td><td>32%</td><td>77%</td></tr></...
b0422b2ff0e87dbcecb96fcf18ff320ce2f3836079c9d1e8c84eb0f91bfa4a6e.png
complex
<table><tr><td colspan="3">Categorical variables</td><td colspan="3">Symptoms class of SCIN-total-score</td><td colspan="2">Univariate</td><td colspan="2">Multiple&#8224;</td></tr><tr><td colspan="2">GST genotype</td><td>Number (%)</td><td>No (0&#8211;5)</td><td>Moderate (6&#8211;9)</td><td>Severe (10&#8211;18)</td><td...
8f7c0fcd53d9c85fe17f95cf121fdfc5b951951355c2c609309018083bbbf990.png
complex
<table><tr><td></td><td colspan="4">Unmatched cohorts</td><td colspan="3">Propensity-score matched cohorts</td></tr><tr><td>Complications</td><td>Human regular insulin <i>n</i> (%) </td><td>Rapid-acting Insulin Analogues <i>n</i> (%) </td><td>Adjusted HR<sup>a</sup> (95% CI)</td><td colspan="2">Human regular insulin <i...
242cf30cfa41e9991f75c5dae55bf35e2f5989ae4e03bd4fc24efa147be68f29.png
complex
<table><tr><td> </td><td colspan="2">Males</td><td colspan="2">Females</td></tr><tr><td> </td><td>AOR</td><td>95% CI</td><td>AOR</td><td>95% CI</td></tr><tr><td>HIV Prevalence</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>&#8804; 0.37%</td><td>1.0</td><td>-</td><td>1.0</td><td>-</td></tr><tr><td>0.38-0.73%</...
d21eee8130a8fec31d2d4339c69fac3f55473a40217e4f3325d1f1e081d25ec7.png
simple
<table><tr><td>Species</td><td>Number detected</td><td>(high; medium; low; no visible mould)</td></tr><tr><td><i>Epicoccum nigrum</i></td><td>15</td><td>(7,2,4,2)</td></tr><tr><td><i>Cladosporium cladosporioides</i></td><td>7</td><td>(3,3,1,0)</td></tr><tr><td><i>Aureobasidium pullulan</i></td><td>4</td><td>(1,1,2,0)</...
797f0effba259b4e68a1f023b5e4f0b86ef6ec09e2688f1d0b603a17f1c06e7f.png
simple
<table><tr><td>Complications</td><td>Survivors (n = 46)</td><td>Non-survivors (n = 29)</td><td>P value<sup>a</sup></td></tr><tr><td>ARDS, n (%)</td><td>17 (37.6)</td><td>25 (86.2)</td><td>&lt;.001</td></tr><tr><td>Pneumonia, n (%)</td><td>41 (89.1)</td><td>27 (93.1)</td><td>.866</td></tr><tr><td>Arrhythmia, n (%)</td><...
4365e1113c9bc0cf76d2599cb1705943e611441cb404884c11323694de9b80d7.png
complex
<table><tr><td colspan="2">ROSA item</td><td>Symptom domain</td><td>Factor</td><td>Loading</td></tr><tr><td>1</td><td>The patient is able to remember events from a long time ago.</td><td>Cognition</td><td>Factor 1</td><td>0.6857</td></tr><tr><td>2</td><td>The patient is able to remember events of the recent past.</td><...
3825c1ca913079c36b99321c86fc65aa6b50dc7fd38a4644ea62c4a553cdee9b.png
complex
<table><tr><td></td><td>Hill and Upchurch7</td><td>Alkema <i>et al</i>2</td></tr><tr><td>Type</td><td>Prescriptive</td><td>Descriptive</td></tr><tr><td>Data</td><td>Historical series from four Northwestern European countries (England and Wales, France, the Netherlands and Sweden) and New Zealand, between 1820 and 1964<...
04e2fc55ef09fa6496ca2868f1c0e157a7225a1872560c46ade7c1b1bd7f484f.png
complex
<table><tr><td>Domain name and number</td><td>ROC set No.</td><td>ROC variables</td><td>No. Obs</td><td>AUC</td><td>SENS</td><td>SPEC</td><td>PPV</td><td>NPV</td><td>% Risk of rejecting Ho</td><td>ROC <i>P</i> value</td><td>Odds ratio<sup>+</sup></td><td>Odds ratio <i>P</i> value</td><td>Accuracy</td></tr><tr><td rowsp...
bb57ff60a2c624b34fc1cbcd8535a43a16bbd3f6f0a647380e811cc4f48c55a2.png
simple
<table><tr><td>Chemokine</td><td>Forward primer</td><td>Reverse primer</td><td>Product size (bp)</td></tr><tr><td>CCL-chr25s</td><td>5'-TTCTGCTGTTTTTGGTGTTCA</td><td>5'-GCTTTATCCAGTCCTCATCTGG</td><td>216</td></tr><tr><td>CCL-chr24a</td><td>5'-TACTTCTCAGCTTCCTTGTGGAGA</td><td>5'-CTCATCGTCTTCGTCTTCATTGTT</td><td>250</td>...
1a4f944a7f32d980972b2b639b4015c0eabc555da90f578f207c0d782cc27b0c.png
complex
<table><tr><td>Gender</td><td colspan="2">Male</td></tr><tr><td>Age</td><td colspan="2">10 y</td></tr><tr><td>Diagnosis</td><td colspan="2">Oppositional defiant disorder</td></tr><tr><td>Intellligence quotient (IQ)</td><td colspan="2">59</td></tr><tr><td>NCBRF total score</td><td></td><td></td></tr><tr><td> Baseline</t...
ad00f63b01ab13e483569ceb153c455474ad5006f486b5ebe9f3ff619a9ac7d4.png
simple
<table><tr><td></td><td>Screening</td><td>Pretreatment</td><td>Discharge</td><td>End of Intervention</td><td>Follow-up</td></tr><tr><td>Study visits</td><td></td><td>T0</td><td>T1</td><td>T2</td><td>T3</td></tr><tr><td>Written informed consent</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td>Screening que...
25dde062e7f93af4555fda3db5c415a90fcfacc51556fa70f4a0b552f1eb354e.png
complex
<table><tr><td rowspan="2">Goal</td><td rowspan="2">I have set this goal (<i>N</i>)</td><td rowspan="2">Since joining K-DPP, I have made lifestyle changes to achieve this goal (%)</td><td colspan="3">I will continue to make these changes after the intervention</td></tr><tr><td>Very likely (%)</td><td>Likely (%)</td><td...
3feac42582fc27ac74384718b9fbeafd304bf75628d19ee29cec85efa9e3bf13.png
simple
<table><tr><td>Isoform</td><td>Substrate</td><td>Metabolite</td><td>Ranges of substrate concentrations in the incubations, &#956;M</td><td>Fluorescence detection excitation/emission</td></tr><tr><td>CYP1A</td><td>ER</td><td>resorufin</td><td>0.1&#8211;12.0</td><td>560/586 nm</td></tr><tr><td>CYP2A</td><td>coumarin</td>...
3fc81942f717d9bb8dc56175eef9044b2651a3669868587e5eb6785c6e7a376c.png
complex
<table><tr><td>SNPs</td><td>No. of every SNP type</td><td>Caused by</td><td>Total No. of transition and transversion</td></tr><tr><td>A/G</td><td>28769</td><td rowspan="2">Transition</td><td rowspan="2">53208</td></tr><tr><td>C/T</td><td>24439</td></tr><tr><td>A/C</td><td>6832</td><td rowspan="4">Transversion</td><td r...
3643a862c28b44139ae096ec26c766f3ef21ec85ee067d78f30dc287ea94ee78.png
simple
<table><tr><td>Term</td><td>Definition</td></tr><tr><td>SP-trEMBL</td><td>Sequence dataset containing 2,241,227 sequences from the Swiss-Prot (version 48.1) and TrEBML (version 31.1) sequence databases.</td></tr><tr><td>Integr8_263</td><td>Sequence dataset containing 913,094 sequences from 263 completed genomes listed ...
b8163d45e8a1a6872fc8d05a543655ed4ca02a8c3007bd50787b5ceca8bc4c99.png
simple
<table><tr><td></td><td>EDA group (n = 68)</td><td>Opioid group (n = 98)</td><td>p-value</td></tr><tr><td>Age (years)</td><td>59.3 &#177; 16.0</td><td>59.9 &#177; 15.3</td><td>n.s.</td></tr><tr><td>Male gender (%)</td><td>58.8</td><td>66.3</td><td>n.s.</td></tr><tr><td>Hospital stay (days)</td><td>9.8 &#177; 5.7</td><t...
000221630ba33f9118f2671a715d6962e08d6b76a5a0c77a9fe26c291df763b0.png
complex
<table><tr><td></td><td colspan="2">PD-L1 Expression</td><td><i>*P</i> value</td></tr><tr><td></td><td>+</td><td>-</td><td></td></tr><tr><td>E-Cadherin</td><td></td><td></td><td></td></tr><tr><td>Down-regulated (&#8804;70 %)</td><td>9 (47)<sup>a</sup></td><td>10 (53)</td><td>0.039</td></tr><tr><td>Positive (&gt; 70 %)<...
aaee931a2962f3d966b27880c7684593d5a03d18218a71a870277745b3cff977.png
complex
<table><tr><td>Reference</td><td colspan="2">Numbers studied</td><td>Type of controls</td><td>Susceptibility</td><td>Severity</td><td>Ethnicity</td></tr><tr><td></td><td>Cancer</td><td>Controls</td><td></td><td></td><td></td><td></td></tr><tr><td>Hefler LA et al, 2005 [58]</td><td>269</td><td>227</td><td>Women visiting...
ab8fda155873ef049ed4f29a6a4707c13f1b03dbd083de3fba9590d487a23146.png
complex
<table><tr><td></td><td colspan="4">Region of interest (ROI)</td></tr><tr><td>Period (months)</td><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td colspan="5">Monoblock</td></tr><tr><td> 0&#8211;12</td><td>&#8211;0.16 (&#8211;0.22 to &#8211;0.10)</td><td>&#8211;0.16 (&#8211;0.24 to &#8211;0.08)</td><td>&#8211;0.09 ...
d6fc0ba92d229512af81bbbf1091cfbb78caff6d499f57d6483b64c424a41bb6.png
complex
<table><tr><td></td><td colspan="2">Group A</td><td colspan="2">Group B</td><td></td></tr><tr><td></td><td colspan="2">6&#8211;8 years (<i>n</i> = 11)</td><td colspan="2">9&#8211;10 years (<i>n</i> = 17)</td><td rowspan="2"><i>P</i> value</td></tr><tr><td></td><td>median</td><td>range</td><td>median</td><td>range</td><...
a838176a8382dfeaef0b6b7220b7a321746b2fe1888393b97f2de964deb0e54d.png
simple
<table><tr><td>Simulation Results</td><td>Yeast 5</td><td>Yeast 6</td></tr><tr><td>Auxotroph-inducing genes</td><td>92</td><td>93</td></tr><tr><td>Correct auxotrophy predictions</td><td>57</td><td>64</td></tr><tr><td>Mutant incorrectly predicted to be viable in minimal medium</td><td>32</td><td>26</td></tr><tr><td>Muta...
6880acc786d2989f4499d641db3f010f71c8f6a3f66724cfb58c3b4ccf2d2890.png
complex
<table><tr><td></td><td colspan="3">Group C</td><td colspan="3">Group B</td></tr><tr><td>Subgroups</td><td>Normotensive(<i>n</i> = 41)</td><td>Treated HT(<i>n</i> = 7)</td><td>Untreated HT(<i>n</i> = 7)</td><td>Normotensive(<i>n</i> = 41)</td><td>Treated HT(<i>n</i> = 7)</td><td>Untreated HT(<i>n</i> = 4)</td></tr><tr>...
6288801ae9ebc7debebf85601cc88d039f643d96ba49f1c42431d9b5977ed83a.png
complex
<table><tr><td rowspan="2">Variables</td><td colspan="2">Univariate<sup>a</sup></td><td colspan="2">Multivariate<sup>a</sup></td></tr><tr><td>HR (95 % CI)</td><td><i>P</i> value</td><td>HR (95 % CI)</td><td><i>P</i> value</td></tr><tr><td colspan="5">Baseline characteristics</td></tr><tr><td>Age &lt;70 y (vs. &#8805;70...
236061c79ffbc38b328ed065c3528f3d28410135e251d379b3bbf6da7e0e9136.png
simple
<table><tr><td>Subgroups</td><td>n</td><td>Cases of the grade of tracheal intubation conditions (1/2/3/4)</td><td>Cases of the anaphylaxis score (0/1/2/3)</td><td>Duration of surgery (min)</td></tr><tr><td>Group 1</td><td>39</td><td>29/10/0/0</td><td>32/7/0/0</td><td>69 &#177; 34</td></tr><tr><td>Group 2</td><td>37</td...
4cb8ec2b1f3a483911f22758fff18c2b04f2ee66d5fed2eb550b3c1092a987e4.png
simple
<table><tr><td>Demographic Characteristics</td><td>TOTAL</td><td>%</td></tr><tr><td>Female</td><td>15</td><td>75%</td></tr><tr><td>Race</td><td></td><td></td></tr><tr><td> White</td><td>15</td><td>75%</td></tr><tr><td> Black</td><td>4</td><td>20%</td></tr><tr><td> Asian</td><td>1</td><td>5%</td></tr><tr><td>Age</td><td...
f069b52cc2fe1db61c77941dc1bfb5b21d14bbd821dac229479c2a34dd96c4f5.png
complex
<table><tr><td></td><td></td><td colspan="2">Using allopurinol</td></tr><tr><td>Factor</td><td>Frequency (%)</td><td>No (%)</td><td>Yes (%)</td></tr><tr><td>Age Mean (SD)</td><td>65.6 (12.5)</td><td>65.1 (13.4)</td><td>65.9 (11.6)</td></tr><tr><td>Gender (Male %)</td><td>990 (83.6)</td><td>390 (79.6)</td><td>544 (86.4)...
f28b1745581ddc6333f0b06cdc9c279e65fdf656e31ad893b6f7fa3ad524a594.png
simple
<table><tr><td>MiR</td><td>Parametric p-value</td><td>FDR</td><td>Permutation p-value</td><td>Geom mean of intensities in class 1</td><td>Geom mean of intensities in class 2</td><td>Geom mean of intensities in class 3</td><td>Geom mean of intensities in class 4</td></tr><tr><td>hsa-miR-204-4373094</td><td>0.00004</td><...
b1aeac26679b03209d72b8bdc3d7c7e4de71dcc23f8b542435b2d88beaa48f64.png
simple
<table><tr><td>Test</td><td>TAA/TAD (%)</td><td>Control (%)</td><td>P-value</td></tr><tr><td>White Blood Cell</td><td> </td><td> </td><td> </td></tr><tr><td>Normal</td><td>93 (70)</td><td>103 (77)</td><td>0.29</td></tr><tr><td>Low (&lt;3 million cells/mcL)</td><td>8 (6)</td><td>9 (7)</td><td>1</td></tr><tr><td>High (&g...
c9d894ccb57fd873bb5b5b4cf479024ea4f7715feee7e22eda8b6e3c4ec0cf8c.png
simple
<table><tr><td></td><td>Count</td><td>%</td></tr><tr><td>He/she used to work but is currently unemployed</td><td>0</td><td>0.00</td></tr><tr><td>He/she never worked and neither does now</td><td>0</td><td>0.00</td></tr><tr><td>Clerk (civil or private)</td><td>338</td><td>63.41</td></tr><tr><td>Free professional (tradesm...
8f9e8870f4cd5f6bb1f4e98c06cfd46e45330158180592ad0baaba6edecb1f80.png
simple
<table><tr><td>Variables</td><td>N (%)</td><td>Prevalence of Internet use (%)<sup>a</sup></td><td>Total scores<sup>b</sup></td><td>Prevalence of AIA (%)<sup>c,d</sup></td></tr><tr><td>Paternal education (missing 23)</td><td> </td><td><i>p</i> &lt;0.001</td><td><i>p</i> &lt;0.001</td><td><i>p =</i>0.01</td></tr><tr><td>...
f2d9d750017e9a50421c8de909d705203eb8fa763ddb698ae3312a40e8f664ef.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">Mean &#177; SD before and after treatment with</td></tr><tr><td>PZQ</td><td>ARA</td><td>PZQ + ARA</td></tr><tr><td>Children</td><td>84</td><td>88</td><td>83</td></tr><tr><td colspan="4">Parameter</td></tr><tr><td colspan="4"> PT (seconds)</td></tr><tr><td>Before</td><td>1...
9e32a35158626c24a7f9c17a80c360ee7a866599257474c00580b028bb472b28.png
complex
<table><tr><td></td><td colspan="2">PLK1</td><td colspan="2">PAK4</td><td colspan="2">PAK5</td><td colspan="2">PAK6</td></tr><tr><td></td><td>SSS</td><td>GAP</td><td>SSS</td><td>GAP</td><td>SSS</td><td>GAP</td><td>SSS</td><td>GAP</td></tr><tr><td>PLK1</td><td>0.000</td><td>100</td><td>0.981</td><td>39.688</td><td>0.976...
1aa1585031b997a442f81191f82dee78094a186a444d500fabbf77630663a34e.png
simple
<table><tr><td> </td><td>Hazard ratio</td><td>95% confidence interval</td><td><i>p</i> value</td></tr><tr><td>Mean age<sup><i>&#8727;</i></sup></td><td>1.026</td><td>1.013&#8211;1.040</td><td>&lt;0.001</td></tr><tr><td>Country of birth, Nordic country</td><td>1.446</td><td>0.980&#8211;2.135</td><td>0.063</td></tr><tr><...
7123cf308f247dbde38f3b1d735d14cf94b74128a654bc07ec8a12bbc61bb6ef.png
simple
<table><tr><td>Cardiometabolic disease outcome</td><td>Amount quintile 1</td><td>Amount quintile 2</td><td>Amount quintile 3</td><td>Amount quintile 4</td><td>Amount quintile 5</td><td><i>P</i>-trend</td></tr><tr><td>Odds ratio (95% CI)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cardiometab...
2467cea2ebd88e34eb0b80fac644b764a51dd512bc25d7e8aafe47c50838b15d.png
simple
<table><tr><td>Cluster ID</td><td>No. of sequences</td><td>Percentage of effective siRNAs (%)</td></tr><tr><td>C1</td><td>134</td><td>94</td></tr><tr><td>C2</td><td>150</td><td>70.7</td></tr><tr><td>C3</td><td>125</td><td>70.4</td></tr><tr><td>C4</td><td>147</td><td>61.9</td></tr><tr><td>C5</td><td>141</td><td>43.3</td...
5b2605e0acac303ad25e730289eab19d7608853a166eca1d036b6676f3aed78c.png
simple
<table><tr><td></td><td>No. Patients (%)</td><td>Methylation (%)</td><td><i>P</i></td></tr><tr><td>All patients </td><td>50 (100)</td><td>31( 62)</td><td></td></tr><tr><td> Male</td><td>42 ( 84)</td><td>27 (64)</td><td></td></tr><tr><td> Female</td><td>8 (16)</td><td>4 (50)</td><td>0.450</td></tr><tr><td>Site</td><td><...
f95e31829130f0eb250596c789b2f739fff2d6943061f70339fe68f6dc09632c.png
simple
<table><tr><td>Method</td><td>Resnik</td><td>Relevance</td><td>Wang</td><td>NETSIM</td><td>NETSIM2</td></tr><tr><td>25%</td><td>0.07</td><td>0.15</td><td>0.17</td><td>0.12</td><td>0.002</td></tr><tr><td>50%</td><td>0.17</td><td>0.43</td><td>0.40</td><td>0.47</td><td>1.94</td></tr><tr><td>75%</td><td>0.42</td><td>1.03</...
5323677ce9e9a78d3679fdf3b1a9728be1da2c38afc4ee09e1eb4ea06dc87c1b.png
complex
<table><tr><td> </td><td colspan="3">Without DM (n = 334)</td><td colspan="3">With DM (n = 122)</td></tr><tr><td>Characteristics</td><td>VAT T1 (n = 111)</td><td>VAT T2 (n = 112)</td><td>VAT T3 (n = 111)</td><td>VAT T1 (n = 40)</td><td>VAT T2 (n = 41)</td><td>VAT T3 (n = 41)</td></tr><tr><td>Calcified plaque</td><td>1....
1af6852f229bbcd9d07b5c0fed52bc497c857c18e472ad593bc85610806d25e6.png
simple
<table><tr><td></td><td>Grenoble (n = 232)</td><td>Montpellier (n = 128)</td><td>Paris (n = 272)</td><td>Total (n = 632)</td></tr><tr><td>Genotype, %</td><td></td><td></td><td></td><td></td></tr><tr><td>AA</td><td>16.8</td><td>21.9</td><td>15.4</td><td>17.3</td></tr><tr><td>AG</td><td>47.0</td><td>46.9</td><td>49.6</td...
4d9f9af861cc3546d23538fa3ddcf669fb9ca2caea203837656f0e84fb99f0b2.png
simple
<table><tr><td>Factor</td><td>Score</td></tr><tr><td>Vascular invasion</td><td></td></tr><tr><td> no</td><td>0</td></tr><tr><td> yes</td><td>2.6</td></tr><tr><td>BCLC stage</td><td></td></tr><tr><td> 0-A</td><td>0</td></tr><tr><td> B-C</td><td>1.3</td></tr><tr><td>MiR-145</td><td></td></tr><tr><td> negative</td><td>0</...
58005f8928fb67fd24a5bd42182e6f931a247f2f76c160989cadfe0111b366f1.png
simple
<table><tr><td></td><td>Exercise Sample</td><td>Physical Activity Sample</td></tr><tr><td>GoF</td><td>.412 [.436]</td><td>.554 [.564]</td></tr><tr><td>APC</td><td>.218; <i>p</i> &lt; .001 [.207; <i>p</i> &lt; .001]</td><td>.291; <i>p</i> &lt; .001 [.252; <i>p</i> &lt;. 001]</td></tr><tr><td>ARS</td><td>.195; <i>p</i> =...
8af71613ecb69d4c94e59ae07236a24faf7ec2bf7200c2e3bc6344688731df7f.png
simple
<table><tr><td>Time for data collection</td><td>Participants in the interviews</td></tr><tr><td>May&#8211;September 2013</td><td>Unit managers, n = 20Regional coordinators, n = 4Officials, n = 24</td></tr><tr><td>May&#8211;September 2014</td><td>Unit managers, n = 5Officials, n = 16</td></tr></table>